Skip to main content

Table 6 Liver function impairment grade of patient pre and post DEB-TACE treatment

From: Efficacy and safety profile of drug-eluting beads transarterial chemoembolization by CalliSpheres® beads in Chinese hepatocellular carcinoma patients

Parameters Baseline (N = 99) 1 week post treatment (N = 91) 1–3 month post treatment (N = 88) P value* P value#
ALB (n)     < 0.001 0.134
 Grade 0 8 59 76
 Grade 1 10 26 11
 Grade 2 2 6 1
 Grade 3 0 0 0
 Grade 4 0 0 0
TBIL (n)     < 0.001 0.643
 Grade 0 67 26 59
 Grade 1 23 36 21
 Grade 2 9 25 6
 Grade 3 0 4 2
 Grade 4 0 0 0
ALT (n)     < 0.001 0.614
 Grade 0 76 32 63
 Grade 1 20 37 23
 Grade 2 3 8 2
 Grade 3 0 13 0
 Grade 4 0 1 0
AST (n)     < 0.001 0.218
 Grade 0 62 25 54
 Grade 1 35 42 29
 Grade 2 2 12 3
 Grade 3 0 10 2
 Grade 4 0 1 0
  1. Data was presented as count. Comparison among groups was determined by Wilcoxon signed rank sum test. P < 0.05 was considered significant. *P value of liver function related biochemical indexes of patients from baseline to 1 week post treatment. #P value of liver function related biochemical indexes of patients from baseline to 1–3 month post treatment. ALB Albumin, TBIL Total bilirubin, ALT Alanine aminotransferase, AST Aspartate aminotransferase